CCMI
BMRN icon

Creative Capital Management Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History

Creative Capital Management Investments’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.86K Buy
+50
New +$2.74K ﹤0.01% 654

Other funds holding BMRN

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
CF
Covea Finance Paris, France $3.17B AUM 35.01% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Creative Capital Management Investments's BMRN Position: Q2 2026 in Review

Creative Capital Management Investments opened a new position in BioMarin Pharmaceuticals (BMRN) in Q2 2026: 50 shares worth $2.86K. The stake represents ﹤0.01% of the portfolio and ranks #654 among its holdings.

108 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Creative Capital Management Investments held 50 shares of BioMarin Pharmaceuticals worth $2.86K as of Q2 2026.
  • BioMarin Pharmaceuticals was a new Creative Capital Management Investments position in Q2 2026.
  • BioMarin Pharmaceuticals made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #654 holding.
  • 108 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.